CD274 and melanoma: Treatment of the B16.OVA murine melanoma cells with different MOI of Ad5Δ24 anti-PD-L1-scFv in the presence of splenocytes, resembling an in-vitro simplified tumoral immune system environment, induced a more robust effect compared to the treatments with the virus or splenocytes alone.